NCT05115006 A Study of Adjuvant Melanoma Stakeholder Treatment Preferences Status COMPLETED Phase N/A
NCT05093790 A Study to Evaluate BMS-986141 Added on to Aspirin or Ticagrelor or the Combination, on Thrombus Formation in a Thrombosis Chamber Model in Participants With Stable Coronary Artery Disease and Healthy Participants Status COMPLETED Phase PHASE2
NCT05088889 Maintenance Ipilimumab + Nivolumab Post Induction Chemotherapy + SBRT for First Line Treatment Stage IV Pancreatic Cancer Status RECRUITING Phase PHASE1
NCT05077956 Sema 4A as a Marker for Inflammatory Disease in Multiple Sclerosis Status WITHDRAWN Phase N/A
NCT05076175 A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis Status RECRUITING Phase PHASE2/PHASE3
NCT05074992 A Trial of Neoadjuvant Therapy in Patients With Newly Diagnosed Glioblastoma Status TERMINATED Phase PHASE2
NCT05068609 A Study of Nivolumab in Participants With Squamous Cell Carcinoma of the Head & Neck (SCCHN) - Patient Reported Outcomes (PRO) Status COMPLETED Phase N/A
NCT05066607 Isatuximab Plus Pomalidomide and Dexamethasone Association for Patients With AL Amyloidosis Not in VGPR or Better After Any Previous Therapy Status RECRUITING Phase PHASE2
NCT05065762 Measuring the Treatment Preferences of Participants in Japan With Moderate-to-Severe Psoriasis (PsO) Using Discrete Choice Experiment Status COMPLETED Phase N/A
NCT05064787 Evaluating the Feasibility of a Digital Health Coaching Program for Individuals Following CAR T Therapy Status COMPLETED Phase NA
NCT05064436 A Study to Evaluate the Safety, Tolerability, Kinetics, Biodistribution and Repeatability of 11C-BMS-986196 After Intravenous (IV) Administration in Healthy Participants and After Repeat IV Administration in Participants With Multiple Sclerosis Status TERMINATED Phase PHASE1
NCT05051553 A Study to Evaluate the Bioavailability of Fedratinib When Administered in Different Ways to Healthy Adult Participants Status COMPLETED Phase PHASE1
NCT05048212 A Phase II Study of Nivolumab With Ipilimumab and Cabozantinib in Patients With Untreated Renal Cell Carcinoma Brain Metastases Status RECRUITING Phase PHASE2
NCT05044533 A Study Evaluating Quality of Life for Participants With Atrial Fibrillation (AF) Following a Bleed (EQUAL-AF) Status COMPLETED Phase N/A
NCT05043714 Study of NG-641 in Combination With Nivolumab in Metastatic or Advanced Epithelial Tumours Status COMPLETED Phase PHASE1
NCT05034926 A Study of Nivolumab in Participants With Locally Advanced or Metastatic (Stage IIIB-IV) Non-Small Cell Lung Cancer (NSCLC) With Squamous and Non-Squamous Histology After Prior Chemotherapy Treated in Real World Settings in Greece and Cyprus Status COMPLETED Phase N/A
NCT05027061 A Study of Participants With Non-Valvular Atrial Fibrillation (NVAF) Treated or Untreated With Oral Anticoagulant in the National Cerebral and Cardiovascular Center (NCVC) in Japan Status COMPLETED Phase N/A
NCT05017545 Carfilzomib and Belatacept for Desensitization Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2